Regarding the latter, the majority of preclinical studies using TORC1 inhibitors may have achieved suppressive effects on renal cyst growth because treatment was initiated prior to the peak in TKV or the time of maximal cystic epithelial cell (CEC) proliferation [5] [6, 12], [8], [7]. The gene discussed is CRTC1; the disease is Renal cyst.